Adherence to Tumor Board Recommendations in the Treatment of Patients with Hepatocellular Carcinoma.
Yueming CaoCatherine MezzacappaAriel JaffeMario StrazzaboscoTamar H TaddeiPublished in: Journal of multidisciplinary healthcare (2023)
Most forms of non-adherence to MDLTB recommendations were unavoidable; however, treatment discordance in the management of patients with BCLC Stage A unifocal disease may present an opportunity for clinically significant quality improvement.